CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Cipla Ltd

Cipla Ltd

BSE 500087 CIPLA INE059A01026
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 50NIFTY 500

Filing rhythm · 60 trading days

37 filings · 9 material · busiest 2026-07-23

What it files

General16 Newspaper Publication3 Change in Management3 ESOP Allotment2 Analyst / Investor Meet2 AGM / EGM2 Scheme of Arrangement1 Concall Transcript1

Filings

37 in the window

  1. 25 August 2026

    General

    USFDA Inspection At Company'S Manufacturing Facility In Pithampur, India

    Please find enclosed disclosure

    Company Update / General View filing →

  2. 19 August 2026

    Scheme of Arrangement

    Scheme of Arrangement

    Cipla has informed the exchange about receipt of order from Hon'ble NCLT, Mumbai Bench

    Company Update / Scheme of Arrangement View filing →

  3. 11 August 2026

    General

    Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find attached disclosure on ESG Ratings.

    Company Update / General View filing →

  4. 4 August 2026

    General

    Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA

    Please find enclosed intimation.

    Company Update / General View filing →

  5. 31 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....

    Company Update / Allotment of ESOP / ESPS View filing →

  6. 27 July 2026

    Concall Transcript

    Earnings Call Transcript

    Please find enclosed Earnings Call Transcript - Q1FY27

    Company Update / Earnings Call Transcript View filing →

  7. 27 July 2026

    General

    Cipla Receives U.S. FDA Approval For Generic Advair Diskus®

    Please find enclosed disclosure

    Company Update / General View filing →

  8. 24 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper intimation for unaudited financial results for the quarter ended 30th June, 2026.

    Company Update / Newspaper Publication View filing →

  9. 23 July 2026

    Results

    Financial Results For Quarter Ended 30Th June, 2026

    Please find attached financial results for quarter ended 30th June, 2026

    Result / Financial Results View filing →

  10. 23 July 2026

    Investor Presentation

    Investor Presentation

    Please find attached Investor Presentation

    Company Update / Investor Presentation View filing →

  11. 23 July 2026

    Press Release

    Press Release / Media Release

    Please find attached press release for Q1FY27 financial results

    Company Update / Press Release / Media Release View filing →

  12. 23 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated 23Rd July 2026

    Please find enclosed outcome of Board meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 23 July 2026

    Change in Management

    Change in Management

    Please find enclosed the disclosure relating to the change in CFO.

    Company Update / Change in Management View filing →

  14. 23 July 2026

    Change in Management

    Change in Management

    Please find enclosed the disclosure relating to the change in SMP.

    Company Update / Change in Management View filing →

  15. 23 July 2026

    General

    Grant Of Stock Option And Employee Stock Appreciation Rights

    Please find enclosed disclosure

    Company Update / General View filing →

  16. 23 July 2026

    General

    500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure on Regulation 30(5)

    Company Update / General View filing →

  17. 23 July 2026

    General

    500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  18. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  19. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  20. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  21. 23 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....

    Company Update / Analyst / Investor Meet View filing →

  22. 13 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  23. 8 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    We are enclosing herewith earnings call intimation scheduled to be held on 23rd July 2026.

    Company Update / Analyst / Investor Meet View filing →

  24. 3 July 2026

    General

    Transcript Of The 90Th Annual General Meeting

    Please find enclosed transcript.

    Company Update / General View filing →

  25. 2 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper publication regarding opening of special window of lodgement of transfer and dematerialisation of physical shares.

    Company Update / Newspaper Publication View filing →

  26. 25 June 2026

    General

    Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find attached disclosure on ESG Rating.

    Company Update / General View filing →

  27. 25 June 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Details of voting results of the 90th Annual General Meeting of the Company and Scrutiniser's report

    AGM/EGM / AGM View filing →

  28. 25 June 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please find enclosed Proceedings of AGM

    AGM/EGM / AGM View filing →

  29. 25 June 2026

    Auditor Appointment

    Appointment of Statutory Auditor/s

    Please find enclosed intimation

    Company Update / Appointment of Statutory Auditor/s View filing →

  30. 24 June 2026

    Board Meeting

    Board Meeting Intimation for The Quarter Ended 30Th June, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Cipla Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated ....

    Board Meeting / Board Meeting View filing →

  31. 18 June 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement titled 'Notice to shareholders for transfer of shares to the Investor Education and Protection Fund'

    Company Update / Newspaper Publication View filing →

  32. 16 June 2026

    Change in Management

    Change in Management

    Appointment of Mr Shivam Puri as the CEO - One India Business and a member of the Management Council, designated as a Senior Management Personnel of Company w.e.f 1st July, 2026

    Company Update / Change in Management View filing →

  33. 16 June 2026

    General

    Grant Of Stock Options And The Employee Stock Appreciation Rights

    Grant of Stock Options and Employee Stock Appreciation Rights (ESARs)

    Company Update / General View filing →

  34. 11 June 2026

    General

    USFDA Inspection At Company'S Manufacturing Facility In Verna, Goa, India

    USFDA inspection at Company's manufacturing facility in Verna, Goa, India

    Company Update / General View filing →

  35. 9 June 2026

    General

    Corrigendum To The Intimation Dated 1St June, 2026 Regarding 'Notice Of The 90Th Annual General Meeting Along With Integrated Annual Report For FY 2025-26'

    Please find enclosed corrigendum.

    Company Update / General View filing →

  36. 8 June 2026

    General

    Communication On Tax Deduction At Source On Final Dividend For FY 2025-26

    Please find enclosed email communication dated 8th June, 2026, sent to members of the Company.

    Company Update / General View filing →

  37. 4 June 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    In comppliance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclsoure Requirements), Regulations, 2015, we hereby notify that the Operations and Administrative ....

    Company Update / Allotment of ESOP / ESPS View filing →